FDA 483 - Xenobiotic Laboratories, Inc. - March 28, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of WuXi AppTec Co., Ltd. (doing business as Xenobiotic Laboratories) in Plainsboro, NJ, revealed a significant issue regarding the firm's adherence to its Standard Operating Procedures (SOPs) for reinjection of analytical runs. Specifically, the firm failed to follow established protocols for reinjecting samples during method validation and study sample analysis, leading to the improper reinjection of entire runs instead of specific missed or failing samples. This indicates a deviation from internal quality control procedures in a biopharmaceutical analytical facility.
ID · 012beef3-6a9b-4160-a875-de557d6acfeb